The FDA has granted accelerated approval to sevabertinib as first-line treatment for adults with locally advanced or metastatic non-squamous non-small cell lung cancer. The approval of sevabertinib (Hyrnuo, Bayer Healthcare Pharmaceuticals), which expands upon the agent’s existing indication for patients who received…
Placebos in Cancer Clinical Trials: What Patients Need to Know Cure Today
Prostate Cancer: Exercise Program Reduces Treatment Side Effects healthline.com
4th Tanzania International Cancer Conference (TICC 2026) oncodaily.com
As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer cancerletter.com
Израильские ученые разработали недорогой и точный анализ крови для выявления рака легких stmegi.com
Has pancreatic cancer met its match? news.harvard.edu
Cancer cell metabolism may play a key role in tumors' ability to evade the immune system. In a study published in the Journal for ImmunoTherapy of Cancer, researchers from GIGA demonstrate that methylglyoxal, a byproduct of tumor metabolism, contributes to the creation of an environment that favors the progression of…
Natalie Bradford: 26,350 Stories – The Data Behind Childhood Cancer Research in Australia Oncodaily
How advancements in blood cancer research are saving lives wxxinews.org
An international research team led by Dr. Lucia Torres Fernández from the working groups of Professor Dr. Julie George and Professor Dr. Roman Thomas at the University of Cologne has identified a critical dependency in small cell lung cancer (SCLC) that can be exploited therapeutically.
Prostate Cancer Genomic Analysis Links Mutational Footprints to Clinical Outcomes Inside Precision Medicine
«Я не победила рак груди»: Симоньян опровергла новости о своем выздоровлении 7days.ru